From Sino Biological Inc. Sep 13 2025 CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors. On June 1, 2025,  The Lancet published positive results from the world's first randomized controlled trial of CLDN18.2 specific CAR-T in gastric cancer, led by Professor Lin Shen’s team at Peking University. The study reported significantly prolonged progression-free survival and a 44 % improvement in overall survival. Recently,